Ashford Capital Management Inc Ligand Pharmaceuticals Inc Transaction History

Ashford Capital Management Inc

$733 Million
Q3 2024

A detailed history of Ashford Capital Management Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ashford Capital Management Inc holds 310,407 shares of LGND stock, worth $35.6 Million. This represents 4.24% of its overall portfolio holdings.

Number of Shares

310,407

Previous 322,207 3.66%

Holding current value

$35.6 Million

Previous $27.1 Million 14.53%

% of portfolio

4.24%

Previous 4.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$82.7 - $110.11 $975,860 - $1.3 Million	-11,800 Reduced 3.66%	310,407 $31.1 Million
Q2 2024 Aug 15, 2024	BUY	$68.53 - $87.91 $8.61 Million - $11 Million	125,672 Added 63.94%	322,207 $27.1 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $13.5 Million - $17.5 Million	196,535 New	196,535 $14.4 Million
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $288,769 - $460,742	-3,040 Closed	0 $0
Q2 2021 Aug 26, 2021	SELL	$113.03 - $155.64 $22,606 - $31,127	-200 Reduced 6.17%	3,040 $399,000
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $199,040 - $431,660	-2,000 Reduced 38.17%	3,240 $494,000
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $35,824 - $50,688	-400 Reduced 7.09%	5,240 $499,000
Q2 2020 Aug 17, 2020	SELL	$68.28 - $123.65 $99,688 - $180,529	-1,460 Reduced 20.56%	5,640 $631,000
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $449,927 - $765,948	7,100 New	7,100 $516,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $9.28 Million - $12.5 Million	-87,630 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$128.36 - $272.13 $237,209 - $502,896	1,848 Added 2.15%	87,630 $11.9 Million
Q3 2018 Nov 15, 2018	BUY	$211.18 - $274.49 $43,291 - $56,270	205 Added 0.24%	85,782 $23.5 Million
Q2 2018 Aug 15, 2018	SELL	$150.77 - $207.98 $24,877 - $34,316	-165 Reduced 0.19%	85,577 $17.7 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $5.86 Million - $7.71 Million	-42,245 Reduced 33.01%	85,742 $14.2 Million
Q4 2017 Feb 15, 2018	SELL	$128.36 - $147.04 $584,038 - $669,032	-4,550 Reduced 3.43%	127,987 $17.5 Million
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $33,854 - $38,623	280 Added 0.21%	132,537 $18 Million
Q2 2017 Aug 21, 2017	BUY	N/A	132,257	132,257 $16.1 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.

Account

Ashford Capital Management Inc Ligand Pharmaceuticals Inc Transaction History